130 related articles for article (PubMed ID: 25263391)
1. eIF4E-mediated translational control of cancer incidence.
Bitterman PB; Polunovsky VA
Biochim Biophys Acta; 2015 Jul; 1849(7):774-80. PubMed ID: 25263391
[TBL] [Abstract][Full Text] [Related]
2. eIF4E threshold levels differ in governing normal and neoplastic expansion of mammary stem and luminal progenitor cells.
Avdulov S; Herrera J; Smith K; Peterson M; Gomez-Garcia JR; Beadnell TC; Schwertfeger KL; Benyumov AO; Manivel JC; Li S; Bielinsky AK; Yee D; Bitterman PB; Polunovsky VA
Cancer Res; 2015 Feb; 75(4):687-97. PubMed ID: 25524901
[TBL] [Abstract][Full Text] [Related]
3. Signalling to eIF4E in cancer.
Siddiqui N; Sonenberg N
Biochem Soc Trans; 2015 Oct; 43(5):763-72. PubMed ID: 26517881
[TBL] [Abstract][Full Text] [Related]
4. Mnks, eIF4E phosphorylation and cancer.
Proud CG
Biochim Biophys Acta; 2015 Jul; 1849(7):766-73. PubMed ID: 25450520
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors.
Larsson O; Li S; Issaenko OA; Avdulov S; Peterson M; Smith K; Bitterman PB; Polunovsky VA
Cancer Res; 2007 Jul; 67(14):6814-24. PubMed ID: 17638893
[TBL] [Abstract][Full Text] [Related]
6. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
7. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
9. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.
Graff JR; Konicek BW; Vincent TM; Lynch RL; Monteith D; Weir SN; Schwier P; Capen A; Goode RL; Dowless MS; Chen Y; Zhang H; Sissons S; Cox K; McNulty AM; Parsons SH; Wang T; Sams L; Geeganage S; Douglass LE; Neubauer BL; Dean NM; Blanchard K; Shou J; Stancato LF; Carter JH; Marcusson EG
J Clin Invest; 2007 Sep; 117(9):2638-48. PubMed ID: 17786246
[TBL] [Abstract][Full Text] [Related]
11. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles of translation factor eIF4E in the nucleus.
Strudwick S; Borden KL
Differentiation; 2002 Mar; 70(1):10-22. PubMed ID: 11963652
[TBL] [Abstract][Full Text] [Related]
13. eIF4E is a central node of an RNA regulon that governs cellular proliferation.
Culjkovic B; Topisirovic I; Skrabanek L; Ruiz-Gutierrez M; Borden KL
J Cell Biol; 2006 Nov; 175(3):415-26. PubMed ID: 17074885
[TBL] [Abstract][Full Text] [Related]
14. Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils.
Robichaud N; Hsu BE; Istomine R; Alvarez F; Blagih J; Ma EH; Morales SV; Dai DL; Li G; Souleimanova M; Guo Q; Del Rincon SV; Miller WH; Ramón Y Cajal S; Park M; Jones RG; Piccirillo CA; Siegel PM; Sonenberg N
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2202-E2209. PubMed ID: 29463754
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
[TBL] [Abstract][Full Text] [Related]
17. Dissecting eIF4E action in tumorigenesis.
Wendel HG; Silva RL; Malina A; Mills JR; Zhu H; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Teruya-Feldstein J; Pelletier J; Lowe SW
Genes Dev; 2007 Dec; 21(24):3232-7. PubMed ID: 18055695
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
19. Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.
Hsieh AC; Ruggero D
Clin Cancer Res; 2010 Oct; 16(20):4914-20. PubMed ID: 20702611
[TBL] [Abstract][Full Text] [Related]
20. Initiation of mRNA translation in oncogenesis: the role of eIF4E.
Montanaro L; Pandolfi PP
Cell Cycle; 2004 Nov; 3(11):1387-9. PubMed ID: 15492504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
